Skip to main content

Advertisement

Log in

Antihypertensive Treatment and Sexual Dysfunction

  • Antihypertensive Agents: Mechanisms of Drug Action (HM Siragy and B Waeber, Section Editors)
  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

Sexual dysfunction is frequently encountered in hypertensive patients. Available data indicates that sexual dysfunction is more frequent in treated than in untreated patients, generating the hypothesis that antihypertensive therapy might be associated with sexual dysfunction. Several lines of evidence suggest that differences between antihypertensive drugs exist regarding their effects on sexual function. Older antihypertensive drugs (diuretics, beta blockers) exert detrimental effects on erectile function whereas newer drugs (nebivolol, angiotensin receptor blockers) have neutral or even beneficial effects. Phosphodiesterase (PDE)-5 inhibitors are effective in hypertensive patients and can be safely administered even when multidrug regimes are used. Precautions need to be taken with alpha blockers or patients with uncontrolled high-risk hypertension, while co-administration with nitrates is contraindicated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as:• Of importance •• Of major importance

  1. • Manolis A, Doumas M. Sexual dysfunction: the 'prima ballerina' of hypertension-related quality-of-life complications. J Hypertens. 2008;26:2074–84. A comprehensive review revealing the association of arterial hypertension and sexual dysfunction, and its impact on life quality..

    Article  PubMed  CAS  Google Scholar 

  2. Doumas M, Douma S. Sexual dysfunction in essential hypertension: myth or reality? J Clin Hypertens. 2006;8:269–74.

    Article  Google Scholar 

  3. Doumas M, Douma S. The effect of antihypertensive drugs on erectile function: a proposed management algorithm. J Clin Hypertens. 2006;8:359–64.

    Article  CAS  Google Scholar 

  4. Manolis A, Doumas M. Hypertension and sexual dysfunction. Arch Med Sci. 2009;5:S337–50.

    Google Scholar 

  5. Douma S, Doumas M, Tsakiris A, Zamboulis C. Male and female sexual dysfunction: Is hypertension an innocent bystander or a major contributor? Rev Bras Hypertens. 2007;14:139–47.

    Google Scholar 

  6. Doumas M, Tsakiris A, Douma S, et al. Factors affecting the increased prevalence of erectile dysfunction in Greek hypertensive compared with normotensive subjects. J Androl. 2006;27:469–77.

    Article  PubMed  Google Scholar 

  7. Doumas M, Tsiodras S, Tsakiris A, et al. Female sexual dysfunction in essential hypertension: a common problem being uncovered. J Hypertens. 2006;24:2387–92.

    Article  PubMed  CAS  Google Scholar 

  8. Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217–23.

    PubMed  Google Scholar 

  9. Ayta IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible consequences. Br J Urol Int. 1999;84:50–6.

    Article  CAS  Google Scholar 

  10. Manolis AJ, Doumas M, Viigimaa M, Narkiewitz K. Hypertension and sexual dysfunction. European Society of Hypertension Scientific Newsletter: Update on Hypertension Management 2007;8.

  11. Manolis AJ, Doumas M, Viigimaa M, Narkiewitz K. Hypertension and sexual dysfunction. European Society of Hypertension Scientific Newsletter: Update on Hypertension Management 2011;32.

  12. •• Viigimaa M, Doumas M, Vlachopoulos C, et al. European Society of Hypertension Working Group on Sexual Dysfunction. Hypertension and sexual dysfunction: time to act. J Hypertens. 2011;29:403–7. doi:403. A position paper from the European Society of Hypertension, highlighting the causes of sexual dysfunction in patients with arterial hypertension, and the significance of this entity.

    Article  PubMed  CAS  Google Scholar 

  13. • Esposito K, Giugliano F, Di Palo C, et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA. 2004;291:2978–84. The first randomized study to evaluate the effects of lifestyle modification on erectile function. A significant improvement of erectile function was observed with weight reduction.

    Article  PubMed  CAS  Google Scholar 

  14. Wing RR, Rosen RC, Fava JL, et al. Effects of weight loss intervention on erectile function in older men with type 2 diabetes in the look AHEAD trial. J Sex Med. 2010;7:156–65.

    Article  PubMed  Google Scholar 

  15. Dallal RM, Chernoff A, O’Leary MP, et al. Sexual dysfunction is common in the morbidly obese male and improves after gastric bypass surgery. J Am Coll Surg. 2008;207:859–64.

    Article  PubMed  Google Scholar 

  16. Esposito K, Ciotola M, Giugliano F, et al. Mediterranean diet improves sexual function in women with the metabolic syndrome. Int J Impot Res. 2007;19:486–91.

    Article  PubMed  CAS  Google Scholar 

  17. Esposito K, Ciotola M, Giugliano F, et al. Mediterranean diet improves erectile function in subjects with the metabolic syndrome. Int J Impot Res. 2006;18:405–10.

    Article  PubMed  CAS  Google Scholar 

  18. Hannan JL, Maio MT, Komolova M, Adams MA. Beneficial impact of exercise and obesity interventions on erectile function and its risk factors. J Sex Med. 2009;6:S254–61.

    Article  Google Scholar 

  19. Lamina S, Okoye CG, Dagogo TT. Therapeutic effect of an interval exercise training program in the management of erectile dysfunction in hypertensive patients. J Clin Hypertens. 2009;11:125–9.

    Article  Google Scholar 

  20. Claudino M, Delbin M, Franco-Penteado C, et al. Exercise training ameliorates the impairment of endothelial and nitrergic corpus cavernosum responses in diabetic rats. Life Sci. 2011;88:272–7.

    Article  PubMed  CAS  Google Scholar 

  21. Doumas M, Anyfanti P, Triantafyllou A. Management of erectile dysfunction: do not forget hypertension. Arch Intern Med. 2012;172:597–8.

    PubMed  Google Scholar 

  22. •• Gupta B, Murad H, Clifton M, et al. The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction. Arch Intern Med. 2011;171:1797–803. An important meta-analysis of studies assessing the effect of lifestyle modification on erectile function..

    Article  PubMed  Google Scholar 

  23. Helmy M, Senbel A. Evaluation of vitamin E in the treatment of erectile dysfunction in aged rats. Life Sci. 2012;90:489–94.

    Article  PubMed  CAS  Google Scholar 

  24. Cormio L, Siati M, Lorusso F, et al. Oral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunction. Urology. 2011;77:119–22.

    Article  PubMed  Google Scholar 

  25. Ernst E, Posadzki P, Lee M. Complementary and alternative medicine (CAM) for sexual dysfunction and erectile dysfunction in older men and women: An overview of systematic reviews. Maturitas. 2011;70:37–41.

    Article  PubMed  Google Scholar 

  26. Toblli J, Stella I, Néstor Mazza O, Ferder L, Inserra F. Protection of cavernous tissue in male spontaneously hypertensive rats. Beyond blood pressure control. Am J Hypertens. 2004;17:516–22.

    Article  PubMed  Google Scholar 

  27. Toblli JE, Cao G, Casas G, Mazza ON. In vivo and in vitro effects of nebivolol on penile structures in hypertensive rats. Am J Hypertens. 2006;19:1226–32.

    Article  PubMed  CAS  Google Scholar 

  28. Cordero A, Bertomeu-Martinez V, Mazon P, et al. Erectile dysfunction in high-risk hypertensive patients treated with beta-blockers agents. Cardiovasc Ther. 2010;28:15–22.

    Article  PubMed  CAS  Google Scholar 

  29. Fogari R, Zoppi A, Poletti L, et al. Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study. Am J Hypertens. 2001;14:27–31.

    Article  PubMed  CAS  Google Scholar 

  30. Fogari R, Preti P, Derosa G, et al. Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men. Eur J Clin Pharmacol. 2001;58:177–80.

    Article  Google Scholar 

  31. Fogari R, Zoppi A, Corradi L, et al. Sexual function in hypertensive males treated with lisinopril or atenolol: a cross-over study. Am J Hypertens. 1998;11:1244–7.

    Article  PubMed  CAS  Google Scholar 

  32. Williams GH, Croog SH, Levine S, et al. Impact of antihypertensive therapy on quality of life: effect of hydrochlorothiazide. J Hypertens. 1987;5:S29–35.

    Article  CAS  Google Scholar 

  33. Ko DT, Hebert PR, Coffey CS, et al. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA. 2002;288:351–7.

    Article  PubMed  CAS  Google Scholar 

  34. Brixius K, Middeke M, Lichtenthal A, Jahn E, Schwinger RH. Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men. Clin Exp Pharmacol Physiol. 2007;34:327–31. A randomized study which unveils the beneficial effects of nebivolol on sexual function compared to older beta blockers..

    Article  PubMed  CAS  Google Scholar 

  35. Grimm RH, Grandits GA, Prineas RJ, Mc Donald RH, Lewis CE, Flack JM, et al. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women: Treatment of Mild Hypertension Study (TOMHS). Hypertension. 1997;29:8–14.

    Article  PubMed  CAS  Google Scholar 

  36. Medical Research Council Working Party on mild to moderate hypertension, report of 1981. Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Lancet. 1981;2:539–543.

    Google Scholar 

  37. Wassertheil-Smoller S, Blaufox MD, Oberman A, et al. Effect of antihypertensives on sexual function and quality of life: the TAIM study. Ann Intern Med. 1991;114:613–20.

    PubMed  CAS  Google Scholar 

  38. Lindholm LH, Persson M, Alaupovic P, et al. Metabolic outcome during 1 year in newly detected hypertensives: results of the antihypertensive treatment and lipid profile in a north of Sweden efficacy evaluation (ALPINE study). J Hypertens. 2003;21:1563–74.

    Article  PubMed  CAS  Google Scholar 

  39. Bechara AJ, Cao G, Casabé AR, Romano SV, Toblli JE. Morphological modifications in clitoris and vagina in spontaneously hypertensive rats. Int J Impot Res. 2003;15:166–72.

    Article  PubMed  CAS  Google Scholar 

  40. Fogari R, Preti P, Zoppi A, et al. Effect of valsartan and atenolol on sexual behavior in hypertensive postmenopausal women. Am J Hypertens. 2004;17:77–81.

    Article  PubMed  CAS  Google Scholar 

  41. • Ma R, Yu J, Xu D, et al. Effect of felodipine with irbesartan or metoprolol on sexual function and oxidative stress in women with essential hypertension. J Hypertens. 2011;30:210–6. An important randomized study of combination therapy in hypertensive women, which shows that ARBs exert beneficial effects on female sexual function compared to beta blockers when either drug is combined with calcium antagonists..

    Article  Google Scholar 

  42. Doumas M, Anyfanti P, Lazaridis N. Effects of antihypertensive therapy on female sexual dysfunction: clinically meaningful? J Hypertens 2012; In press.

  43. Kostis JB, Jackson G, Rosen R, et al. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol. 2005;96:313–21.

    Article  PubMed  Google Scholar 

  44. Dusing R. Effect of the angiotensin II antagonist valsartan on sexual function in hypertensive men. Blood Press. 2003;12:S29–34.

    Article  Google Scholar 

  45. Della Chiesa A, Pfifner D, Meier B, et al. Sexual activity in hypertensive men. J Hum Hypertens. 2003;17:515–21.

    Article  PubMed  CAS  Google Scholar 

  46. Llisterri JL, Lozano Vidal JV, Aznar Vicente J, et al. Sexual dysfunction in hypertensive patients treated with losartan. Am J Med Sci. 2001;321:336–41.

    Article  PubMed  CAS  Google Scholar 

  47. Doumas M, Tsakiris A, Douma S, et al. Beneficial effects of switching from beta-blockers to nebivolol on the erectile function of hypertensive patients. Asian J Androl. 2006;8:177–82.

    Article  PubMed  CAS  Google Scholar 

  48. Baumhakel M, Schlimmer N, Bohm M. Effect of irbesartan on erectile function in patients with hypertension and metabolic syndrome. Int J Impot Res. 2008;20:493–500.

    Article  PubMed  CAS  Google Scholar 

  49. Douma S, Doumas M, Petidis K, Triantafyllou A, Zamboulis C. Beta blockers and sexual dysfunction: bad guys – good guys. In: Beta Blockers: New Research – editors: Momoka Endo and Narami Matsumoto. Nova Science Publishers Inc. 2008;1–13.

  50. Baumhakel M, Schimmer N, Kratz M, et al. Cardiovascular risk, drugs and erectile function – a systematic analysis. Int J Clin Pract. 2011;65:289–98.

    Article  PubMed  CAS  Google Scholar 

  51. Silvestri A, Galetta P, Cerquetani E, et al. Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by placebo. Eur Heart J. 2003;24:1928–32.

    Article  PubMed  CAS  Google Scholar 

  52. Cocco G. Erectile dysfunction after therapy with metoprolol: the Hawthorne effect. Cardiology. 2009;112:174–7.

    Article  PubMed  CAS  Google Scholar 

  53. •• Böhm M, Baumhäkel M, Teo K, et al. ONTARGET/TRANSCEND Erectile Dysfunction Substudy Investigators. Erectile Dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNT Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANCEND) Trials. Circulation. 2010;121:1439–46. The first substudy of a large, randomized trial evaluating the effect of ARBs on erectile function. It was found that erectile dysfunction is a strong predictor of cardiovascular events and that ARBs do not have any significant effect on erectile function. It has to be taken into account that ARBs were used on top of previous multidrug antihypertensive treatment..

    Article  PubMed  Google Scholar 

  54. Ballard SA, Gingell CJ, Tang K, et al. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J Urol. 1998;159:2164–71.

    Article  PubMed  CAS  Google Scholar 

  55. Boolell M, Allen MJ, Ballard SA, et al. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res. 1996;8:47–52.

    PubMed  CAS  Google Scholar 

  56. Maggi M, Filippi S, Ledda F, et al. Erectile dysfunction: from biochemical pharmacology to advances in medical therapy. Eur J Endocrinol. 2000;143:143–54.

    Article  PubMed  CAS  Google Scholar 

  57. Jackson G, Benjamin N, Jackson N, et al. Effects of sildenafil citrate on human hemodynamics. Am J Cardiol. 1999;83:13C–20C.

    Article  PubMed  CAS  Google Scholar 

  58. Montague DK, Jarow JP, Broderick GA, et al. Erectile Dysfunction Guideline Update Panel. The management of erectile dysfunction: an AUA update. J Urol. 2005;174:230–9.

    Article  PubMed  Google Scholar 

  59. Emmick JT, Stuewe SR, Mitchell M. Overview of the cardiovascular effects of tadalafil. Eur Heart J. 2002;4:H32–47.

    Article  CAS  Google Scholar 

  60. Zusman RM, Prisant LM, Brown MJ. Effect of sildenafil citrate on blood pressure and heart rate in men with erectile dysfunction taking concomitant antihypertensive medication. Sildenafil Study Group. J Hypertens. 2000;18(12):1865–9.

    Article  PubMed  CAS  Google Scholar 

  61. Kloner RA, Mitchell M, Emmick JT. Cardiovascular effects of tadalafil. Am J Cardiol. 2003;92:37M–46M.

    Article  PubMed  CAS  Google Scholar 

  62. van Ahlen H, Wahle K, Kupper W, et al. Safety and efficacy of vardenafil, a selective phosphodiesterase 5 inhibitor, in patients with erectile dysfunction and arterial hypertension treated with multiple antihypertensives. J Sex Med. 2005;2:856–64.

    Article  PubMed  Google Scholar 

  63. Pickering TG, Shepherd AM, Puddey I, et al. Sildenafil citrate for erectile dysfunction in men receiving multiple antihypertensive agents: a randomized controlled trial. Am J Hypertens. 2004;17:1135–42.

    Article  PubMed  CAS  Google Scholar 

  64. McLaughlin T, Harnett J, Burhani S, Scott B. Evaluation of erectile dysfunction therapy in patients previously nonadherent to long-term medications: a retrospective analysis of prescription claims. Am J Ther. 2005;12:605–11.

    Article  PubMed  Google Scholar 

  65. Scranton RE, Lawler E, Botteman M, et al. Effect of treating erectile dysfunction on management of systolic hypertension. Am J Cardiol. 2007;100:459–63.

    Article  PubMed  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Athanasios Manolis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Manolis, A., Doumas, M. Antihypertensive Treatment and Sexual Dysfunction. Curr Hypertens Rep 14, 285–292 (2012). https://doi.org/10.1007/s11906-012-0276-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-012-0276-5

Keywords

Navigation